Reuters logo
BRIEF-Arcturus Therapeutics to collaborate with Johnson & Johnson
October 19, 2017 / 11:12 AM / a month ago

BRIEF-Arcturus Therapeutics to collaborate with Johnson & Johnson

Oct 19 (Reuters) - Johnson & Johnson

* Arcturus Therapeutics announces strategic collaboration with Johnson & Johnson Innovation to discover and develop RNA medicines

* ‍arcturus Therapeutics says has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals Inc​

* ‍arcturus Therapeutics Inc- agreement includes an option to expand into other infectious and respiratory diseases​

* ‍arcturus Therapeutics - deal was facilitated by Johnson & Johnson innovation center, in California​

* ‍arcturus Therapeutics - cos to work together to develop and commercialize nucleic acid-based drug products for treatment of Hepatitis B

* Arcturus Therapeutics - ‍under agreement, Arcturus will receive an upfront cash payment, research and development support, pre-clinical, development, sales milestone payments​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below